Failure

GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events

News Medical November 27, 2024 0Comment

Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.

Latest Technology

AI Is Now More Creative Than the Average Human

Scientists Uncover a Hidden Early Stage of Alzheimer’s That They Can Stop

Health Psychology

Memories of childhood trauma may shift depending on current relationships

Endangered Galapagos Seabird Makes 3,000-Mile-Detour to California